Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 11 results.
User Information
Export Records
  1. 1.   Mechanisms of HIV-1 drug resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors
  2. Nikolenko, G. N.; Kotelkin, A. T.; Oreshkova, S. F.; Ilyichev, A. A.
  3. Molecular Biology. 2011, Feb; 45(1): 93-109.
  1. 2.   Evaluation of the effect of pyrimethamine, an anti-malarial drug, on HIV-1 replication
  2. Oguariri, R. M.; Adelsberger, J. W.; Baseler, M. W.; Imamichi, T.
  3. Virus Research. 2010, Nov; 153(2): 269-276.
  1. 3.   Apparent defects in processive DNA synthesis, strand transfer, and primer elongation of met-184 mutants of HIV-1 reverse transcriptase derive solely from a dNTP utilization defect
  2. Gao, L.; Hanson, M. N.; Balakrishnan, M.; Boyer, P. L.; Roques, B. P.; Hughes, S. H.; Kim, B.; Bambara, R. A.
  3. Journal of Biological Chemistry. 2008 283(14): 9196-9205.
  1. 4.   Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: Balance between RNase H activity and nucleotide excision
  2. Nikolenko, G. N.; Palmer, S.; Maldarelli, F.; Mellors, J. W.; Coffin, J. M.; Pathak, V. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, FEB 8; 102(6): 2093-2098.
  1. 5.   Mutations in HIV-1 RNase H domain confer high-level resistance to nucleoside reverse transcriptase inhibitors and provide novel insights into the mechanism of nucleotide excision-mediated drug resistance
  2. Nikolenko, G. N.; Palmer, S.; Maldarelli, F.; Mellors, J. W.; Coffin, J. M.; Pathak, V. K.
  3. Antiviral Therapy. 2004, AUG; 9(4): U35-U36.
  1. 6.   Action of Anti-HIV drugs and resistance: Reverse transcriptase inhibitors and protease inhibitors
  2. Imamichi, T.
  3. Current Pharmaceutical Design. 2004 10(32): 4039-4053.
  1. 7.   Wild-type and YMDD mutant murine leukemia virus reverse transcriptases are resistant to 2 ',3 '-dideoxy-3 '-thiacytidine
  2. Halvas, E. K.; Svarovskaia, E. S.; Freed, E. O.; Pathak, V. K.
  3. Journal of Virology. 2000 74(14): 6669-6674.
  1. 8.   Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity
  2. Halvas, E. K.; Svarovskaia, E. S.; Pathak, V. K.
  3. Journal of Virology. 2000 74(1): 312-319.
  1. 9.   Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids
  2. Sarafianos, S. G.; Das, K.; Clark, A. D.; Ding, J. P.; Boyer, P. L.; Hughes, S. H.; Arnold, E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1999 96(18): 10027-10032.
  1. 10.   Touching the heart of HIV-1 drug resistance: the fingers close down on the dNTP at the polymerase active site
  2. Sarafianos, S. G.; Das, K.; Ding, J. P.; Boyer, P. L.; Hughes, S. H.; Arnold, E.
  3. Chemistry & Biology. 1999 6(5): R137-R146.
  1. 11.   In vitro induction of human immunodeficiency virus type 1 variants resistant to phosphoralaninate prodrugs of Z-methylenecyclopropane nucleoside analogues
  2. Yoshimura, K.; Feldman, R.; Kodama, E.; Kavlick, M. F.; Qiu, Y. L.; Zemlicka, J.; Mitsuya, H.
  3. Antimicrobial Agents and Chemotherapy. 1999 43(10): 2479-2483.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel